{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:36:47Z","timestamp":1791387407655,"version":"4.3.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T00:00:00Z","timestamp":1520467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011852","name":"Paracelsus Medical University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011852","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00259-018-3980-9","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T21:34:26Z","timestamp":1520458466000},"page":"1762-1771","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":130,"title":["18F-Fluorocholine PET\/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT\/CT: a prospective dual-centre study in 100 patients"],"prefix":"10.1007","volume":"45","author":[{"given":"Mohsen","family":"Beheshti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Hehenwarter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Paymani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gundula","family":"Rendl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Imamovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert","family":"Rettenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksiy","family":"Tsybrovskyy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Langsteger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pirich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,8]]},"reference":[{"key":"3980_CR1","first-page":"333","volume":"69","author":"ED Taniegra","year":"2004","unstructured":"Taniegra ED. Hyperparathyroidism. Am Fam Physician. 2004;69:333\u20139.","journal-title":"Am Fam Physician"},{"key":"3980_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5152\/UCD.2015.3032","volume":"32","author":"T Madkhali","year":"2016","unstructured":"Madkhali T, Alhefdhi A, Chen H, Elfenbein D. Primary hyperparathyroidism. Ulus Cerrahi Derg. 2016;32:58\u201366. \n                    https:\/\/doi.org\/10.5152\/UCD.2015.3032\n                    \n                  .","journal-title":"Ulus Cerrahi Derg"},{"key":"3980_CR3","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/RLU.0b013e318251e408","volume":"37","author":"D Taieb","year":"2012","unstructured":"Taieb D, Hindie E, Grassetto G, Colletti PM, Rubello D. Parathyroid scintigraphy: when, how, and why? A concise systematic review. Clin Nucl Med. 2012;37:568\u201374. \n                    https:\/\/doi.org\/10.1097\/RLU.0b013e318251e408\n                    \n                  .","journal-title":"Clin Nucl Med"},{"key":"3980_CR4","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","volume":"151","author":"SM Wilhelm","year":"2016","unstructured":"Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, et al. The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151:959\u201368. \n                    https:\/\/doi.org\/10.1001\/jamasurg.2016.2310\n                    \n                  .","journal-title":"JAMA Surg"},{"key":"3980_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ejso.2016.09.016","volume":"43","author":"M Hocevar","year":"2017","unstructured":"Hocevar M, Lezaic L, Rep S, Zaletel K, Kocjan T, Sever MJ, et al. Focused parathyroidectomy without intraoperative parathormone testing is safe after pre-operative localization with 18F-fluorocholine PET\/CT. Eur J Surg Oncol. 2017;43:133\u20137. \n                    https:\/\/doi.org\/10.1016\/j.ejso.2016.09.016\n                    \n                  .","journal-title":"Eur J Surg Oncol"},{"issue":"Suppl 1","key":"3980_CR6","doi-asserted-by":"publisher","first-page":"E2159","DOI":"10.1002\/hed.24027","volume":"38","author":"G Treglia","year":"2016","unstructured":"Treglia G, Sadeghi R, Schalin-Jantti C, Caldarella C, Ceriani L, Giovanella L, et al. Detection rate of (99m) Tc-MIBI single photon emission computed tomography (SPECT)\/CT in preoperative planning for patients with primary hyperparathyroidism: a meta-analysis. Head Neck. 2016;38(Suppl 1):E2159\u201372. \n                    https:\/\/doi.org\/10.1002\/hed.24027\n                    \n                  .","journal-title":"Head Neck"},{"key":"3980_CR7","first-page":"695","volume":"112","author":"S Balogova","year":"2011","unstructured":"Balogova S, Cambal M, Simkova A, Kekenak L, Stecova A, Gregor P, et al. From preoperative to intraoperative detection of hyperfunctioning parathyroid glands using tetrofosmin (99mTc) in primary hyperparathyroidism. Bratisl Lek Listy. 2011;112:695\u2013700.","journal-title":"Bratisl Lek Listy"},{"key":"3980_CR8","first-page":"320","volume":"39","author":"M Ishibashi","year":"1998","unstructured":"Ishibashi M, Nishida H, Hiromatsu Y, Kojima K, Tabuchi E, Hayabuchi N. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands. J Nucl Med. 1998;39:320\u20134.","journal-title":"J Nucl Med"},{"key":"3980_CR9","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s002590100627","volume":"28","author":"H Wakamatsu","year":"2001","unstructured":"Wakamatsu H, Noguchi S, Yamashita H, Yamashita H, Tamura S, Jinnouchi S, et al. Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with (99m)Tc-MIBI, (201)Tl, MRI and US. Eur J Nucl Med. 2001;28:1817\u201327. \n                    https:\/\/doi.org\/10.1007\/s002590100627\n                    \n                  .","journal-title":"Eur J Nucl Med"},{"key":"3980_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1515\/raon-2015-0016","volume":"49","author":"S Rep","year":"2015","unstructured":"Rep S, Lezaic L, Kocjan T, Pfeifer M, Sever MJ, Simoncic U, et al. Optimal scan time for evaluation of parathyroid adenoma with [(18)F]-fluorocholine PET\/CT. Radiol Oncol. 2015;49:327\u201333. \n                    https:\/\/doi.org\/10.1515\/raon-2015-0016\n                    \n                  .","journal-title":"Radiol Oncol"},{"key":"3980_CR11","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.ejrad.2015.05.024","volume":"84","author":"WP Kluijfhout","year":"2015","unstructured":"Kluijfhout WP, Vorselaars WM, Vriens MR, Borel Rinkes IH, Valk GD, de Keizer B. Enabling minimal invasive parathyroidectomy for patients with primary hyperparathyroidism using Tc-99m-sestamibi SPECT-CT, ultrasound and first results of (18)F-fluorocholine PET-CT. Eur J Radiol. 2015;84:1745\u201351. \n                    https:\/\/doi.org\/10.1016\/j.ejrad.2015.05.024\n                    \n                  .","journal-title":"Eur J Radiol"},{"key":"3980_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1967\/s002449910207","volume":"18","author":"WJ Wei","year":"2015","unstructured":"Wei WJ, Shen CT, Song HJ, Qiu ZL, Luo QY. Comparison of SPET\/CT, SPET and planar imaging using 99mTc-MIBI as independent techniques to support minimally invasive parathyroidectomy in primary hyperparathyroidism: a meta-analysis. Hell J Nucl Med. 2015;18:127\u201335. \n                    https:\/\/doi.org\/10.1967\/s002449910207\n                    \n                  .","journal-title":"Hell J Nucl Med"},{"key":"3980_CR13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/MNM.0000000000000262","volume":"36","author":"KK Wong","year":"2015","unstructured":"Wong KK, Fig LM, Gross MD, Dwamena BA. Parathyroid adenoma localization with 99mTc-sestamibi SPECT\/CT: a meta-analysis. Nucl Med Commun. 2015;36:363\u201375. \n                    https:\/\/doi.org\/10.1097\/MNM.0000000000000262\n                    \n                  .","journal-title":"Nucl Med Commun"},{"key":"3980_CR14","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1210\/jc.2002-021095","volume":"88","author":"J Allendorf","year":"2003","unstructured":"Allendorf J, Kim L, Chabot J, DiGiorgi M, Spanknebel K, LoGerfo P. The impact of sestamibi scanning on the outcome of parathyroid surgery. J Clin Endocrinol Metab. 2003;88:3015\u20138. \n                    https:\/\/doi.org\/10.1210\/jc.2002-021095\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"key":"3980_CR15","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.crad.2004.04.005","volume":"59","author":"AT Ahuja","year":"2004","unstructured":"Ahuja AT, Wong KT, Ching AS, Fung MK, Lau JY, Yuen EH, et al. Imaging for primary hyperparathyroidism \u2013 what beginners should know. Clin Radiol. 2004;59:967\u201376. \n                    https:\/\/doi.org\/10.1016\/j.crad.2004.04.005\n                    \n                  .","journal-title":"Clin Radiol"},{"key":"3980_CR16","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/01.sla.0000120072.85692.a7","volume":"239","author":"MS Eigelberger","year":"2004","unstructured":"Eigelberger MS, Cheah WK, Ituarte PH, Streja L, Duh QY, Clark OH. The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited? Ann Surg. 2004;239:528\u201335.","journal-title":"Ann Surg"},{"key":"3980_CR17","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jamcollsurg.2003.12.006","volume":"198","author":"FJ Diaz-Aguirregoitia","year":"2004","unstructured":"Diaz-Aguirregoitia FJ, Emparan C, Gaztambide S, Aniel-Quiroga MA, Busturia MA, Vazquez JA, et al. Intraoperative monitoring of kinetic total serum calcium levels in primary hyperparathyroidism surgery. J Am Coll Surg. 2004;198:519\u201324. \n                    https:\/\/doi.org\/10.1016\/j.jamcollsurg.2003.12.006\n                    \n                  .","journal-title":"J Am Coll Surg"},{"key":"3980_CR18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/00000658-200211000-00001","volume":"236","author":"A Bergenfelz","year":"2002","unstructured":"Bergenfelz A, Lindblom P, Tibblin S, Westerdahl J. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg. 2002;236:543\u201351. \n                    https:\/\/doi.org\/10.1097\/01.SLA.0000032949.36504.C3\n                    \n                  .","journal-title":"Ann Surg"},{"key":"3980_CR19","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00268-002-6619-7","volume":"26","author":"WB Inabnet 3rd","year":"2002","unstructured":"Inabnet WB 3rd, Dakin GF, Haber RS, Rubino F, Diamond EJ, Gagner M. Targeted parathyroidectomy in the era of intraoperative parathormone monitoring. World J Surg. 2002;26:921\u20135. \n                    https:\/\/doi.org\/10.1007\/s00268-002-6619-7\n                    \n                  .","journal-title":"World J Surg"},{"key":"3980_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1072-7515(03)00113-3","volume":"197","author":"ED Dillavou","year":"2003","unstructured":"Dillavou ED, Cohn HE. Minimally invasive parathyroidectomy: 101 consecutive cases from a single surgeon. J Am Coll Surg. 2003;197:1\u20137. \n                    https:\/\/doi.org\/10.1016\/S1072-7515(03)00113-3\n                    \n                  .","journal-title":"J Am Coll Surg"},{"key":"3980_CR21","unstructured":"British Association of Endocrine Surgeons. Guidelines for the surgical management of endocrine disease and training requirements for endocrine surgery. London: British Association of Endocrine Surgeons; 2003."},{"key":"3980_CR22","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1007\/s00268-016-3795-4","volume":"41","author":"T Weber","year":"2017","unstructured":"Weber T, Gadsden M, Schweiz S, Beer A, Luster M. Is C-11 methionine PET\/CT able to localise sestamibi-negative parathyroid adenomas? World J Surg. 2017;41:980\u20135. \n                    https:\/\/doi.org\/10.1007\/s00268-016-3795-4\n                    \n                  .","journal-title":"World J Surg"},{"key":"3980_CR23","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s00259-014-2837-0","volume":"41","author":"L Lezaic","year":"2014","unstructured":"Lezaic L, Rep S, Sever MJ, Kocjan T, Hocevar M, Fettich J. 18F-Fluorocholine PET\/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study. Eur J Nucl Med Mol Imaging. 2014;41:2083\u20139. \n                    https:\/\/doi.org\/10.1007\/s00259-014-2837-0\n                    \n                  .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3980_CR24","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1210\/jc.2014-2821","volume":"99","author":"L Michaud","year":"2014","unstructured":"Michaud L, Burgess A, Huchet V, Lefevre M, Tassart M, Ohnona J, et al. Is 18F-fluorocholine-positron emission tomography\/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism? J Clin Endocrinol Metab. 2014;99:4531\u20136. \n                    https:\/\/doi.org\/10.1210\/jc.2014-2821\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"key":"3980_CR25","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1097\/RLU.0000000000000607","volume":"39","author":"M Orevi","year":"2014","unstructured":"Orevi M, Freedman N, Mishani E, Bocher M, Jacobson O, Krausz Y. Localization of parathyroid adenoma by 11C-choline PET\/CT: preliminary results. Clin Nucl Med. 2014;39:1033\u20138. \n                    https:\/\/doi.org\/10.1097\/RLU.0000000000000607\n                    \n                  .","journal-title":"Clin Nucl Med"},{"key":"3980_CR26","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1507\/endocrj1954.34.965","volume":"34","author":"T Ishizuka","year":"1987","unstructured":"Ishizuka T, Kajita K, Kamikubo K, Komaki T, Miura K, Nagao S, et al. Phospholipid\/Ca2+-dependent protein kinase activity in human parathyroid adenoma. Endocrinol Jpn. 1987;34:965\u20138.","journal-title":"Endocrinol Jpn"},{"key":"3980_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12020-012-9746-4","volume":"43","author":"C Caldarella","year":"2013","unstructured":"Caldarella C, Treglia G, Isgro MA, Giordano A. Diagnostic performance of positron emission tomography using 11C-methionine in patients with suspected parathyroid adenoma: a meta-analysis. Endocrine. 2013;43:78\u201383. \n                    https:\/\/doi.org\/10.1007\/s12020-012-9746-4\n                    \n                  .","journal-title":"Endocrine"},{"key":"3980_CR28","first-page":"92","volume":"43","author":"TR DeGrado","year":"2002","unstructured":"DeGrado TR, Reiman RE, Price DT, Wang S, Coleman RE. Pharmacokinetics and radiation dosimetry of 18F-fluorocholine. J Nucl Med. 2002;43:92\u20136.","journal-title":"J Nucl Med"},{"key":"3980_CR29","first-page":"1766","volume":"37","author":"A Sundin","year":"1996","unstructured":"Sundin A, Johansson C, Hellman P, Bergstrom M, Ahlstrom H, Jacobson GB, et al. PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism. J Nucl Med. 1996;37:1766\u201370.","journal-title":"J Nucl Med"},{"key":"3980_CR30","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1177\/0284185116661878","volume":"58","author":"L Yuan","year":"2017","unstructured":"Yuan L, Liu J, Kan Y, Yang J, Wang X. The diagnostic value of 11C-methionine PET in hyperparathyroidism with negative 99mTc-MIBI SPECT: a meta-analysis. Acta Radiol. 2017;58:558\u201364. \n                    https:\/\/doi.org\/10.1177\/0284185116661878\n                    \n                  .","journal-title":"Acta Radiol"},{"key":"3980_CR31","first-page":"1740","volume-title":"Surgical pathology of the head and neck","author":"L Barnes","year":"2009","unstructured":"Barnes L. Surgical pathology of the head and neck. 2nd ed. New York: Informa Healthcare; 2009. p. 1740\u201350.","edition":"2"},{"key":"3980_CR32","volume-title":"World Health Organization Classification of Tumours. Pathology and genetics: tumours of endocrine organs","author":"R DeLellis","year":"2004","unstructured":"DeLellis R, Lloyd RV, Heitz P, Eng C. World Health Organization Classification of Tumours. Pathology and genetics: tumours of endocrine organs. 1st ed. Lyon: IARC Press; 2004.","edition":"1"},{"key":"3980_CR33","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/BF00834533","volume":"23","author":"RM Aigner","year":"1996","unstructured":"Aigner RM, Fueger GF, Nicoletti R. Parathyroid scintigraphy: comparison of technetium-99m methoxyisobutylisonitrile and technetium-99m tetrofosmin studies. Eur J Nucl Med. 1996;23:693\u20136.","journal-title":"Eur J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-018-3980-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-3980-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-3980-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T20:12:03Z","timestamp":1551989523000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-018-3980-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,8]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["3980"],"URL":"https:\/\/doi.org\/10.1007\/s00259-018-3980-9","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732818053.793571282","asserted-by":"object"}]},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,8]]},"assertion":[{"value":"28 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}